2017 American Transplant Congress
Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.
BackgroundThe Internet has extensive online resources for kidney transplantation recipients. However, it is unclear if these materials are comprehensible for kidney transplant patients. Nearly, one-half…2017 American Transplant Congress
Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.
Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is complex, time…2017 American Transplant Congress
Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.
Urology, Beijing Friendship Hospital, Beijing, China
Background: The purpose of this study was to evaluate the effects and safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with…2017 American Transplant Congress
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.
Urinary concentration is the result of a complex glomerulotubular mechanism, which culpits with the stimulation of aquaporins at the collector tubule, in response to vasopressin…2017 American Transplant Congress
Potential Barriers Hindering Non-Directed (Altruistic) Living Kidney Donors from Donating Their Kidneys.
A. While non-directed kidney donation in the United States is a growing concept that demonstrates the next level of altruism in the U.S., there are…2017 American Transplant Congress
Activation of Inflammation Amplifier in Kidney Graft and Urinary Biomarker for Chronic Rejection.
[Introduction and Objective] Inflammation amplifier (IA), a local chemokine inducer in non-immune cells is induced by simultaneous activation of NFκB and STATs (IL-17, TNFα, and…2017 American Transplant Congress
Comparison of Long Term Survival Outcomes for Everolimus (EVR) vs. Mycophenolic Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant.
In the US, MPA in combination with calcineurin inhibitors (CNI, tacrolimus [TAC] or cyclosporine A [CsA]) is the most commonly used maintenance immunosuppressive therapy post…2017 American Transplant Congress
Anti-CD25mAb Sparing Immunosuppressive Regimen Suppressed Recurrence of Post-Transplant Focal Segmental Glomerular Sclerosis- A Single Center Experience.
Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan
INTRODUCTION: The rate of recurrence of primary focal segmental glomerular sclerosis (FSGS) is problematic, because it often results in very early serious urinary protein secretion…2017 American Transplant Congress
Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.
Human leukocyte antigen-G (HLA-G) is a tolerogenic protein shown to contribute to allograft survival. Dimerized, soluble HLA-G (sHLA-Gd) has been shown to significantly prolong allograft…2017 American Transplant Congress
No Impact of One Year of Everolimus, as Compared to MPA, in the Reversal of Left Ventricular Hypertrophy in Elderly Renal Transplant Recipients – Preliminary Data from Then Everold Study.
It has been suggested that mTor inhibitors may contribute to the reversal of myocardial hypertrophy after transplantation possibly due to its biological effects like enhanced…
- « Previous Page
- 1
- …
- 367
- 368
- 369
- 370
- 371
- …
- 531
- Next Page »